home / stock / evgn / evgn articles
Evogene Ltd. (NASDAQ:EVGN) (TASE: EVGN) announced on Thursday its financial results for the fourth quarter and full-year period ending December 31,...
Agreement reinforces both companies' commitment to developing and bringing innovative biological solutions to farmers BASEL, Switzerland and RE...
The parties will identify and design probiotic bacteria that produce highly sustainable quantities of microbial metabolites, known to improve human...
This first shipment, valued at approximately US$1 million, is part of a framework agreement with a world-leading oil and gas company REHOVOT, Israe...
Evogene Ltd (NASDAQ: EVGN) shares are trading lower by 5.9% to $0.63 Thursday morning after the company received a letter from the Nasdaq indi...
News, Short Squeeze, Breakout and More Instantly...
ICL and Lavie Bio Leverage Artificial Intelligence to Make Significant Advancement in Development of Yield Increasing Bio-Stimulants PR Newswire More than one dozen novel microbes identified for row crops suffering from extreme weather conditions TEL AVIV and ...
Lavie Bio Announces Commercial Expansion of Yalos™ to Winter Wheat PR Newswire Lavie Bio successfully completed testing of Yalos™ for winter wheat and will commence sales across the US for the 2024-2025 season REHOVOT, Israel , July 2, 2024 ...
2024-06-27 08:15:04 ET Alliance Global Partners analyst issues BUY recommendation for EVGN on June 27, 2024 07:06AM ET. The previous analyst recommendation was Buy. EVGN was trading at $0.6436 at issue of the analyst recommendation. The overall analyst consensus : BUY. ...